Winterlight Labs is a Toronto-based company that has developed a proprietary tablet-based technology to assess cognitive health by analyzing speech patterns. Their innovative platform provides fast, objective, and stress-free assessments to detect cognitive impairment associated with dementia and mental illness. The technology is utilized in clinical trials and senior care settings, making it a trusted solution for five of the top ten life sciences companies. Winterlight's differentiation lies in its ability to extract speech-based digital biomarkers, enabling remote assessments and improving the quality of care for patients. Founded in 2015, Winterlight Labs is positioned as a leader in the emerging field of digital biomarkers for cognitive health, with significant traction in clinical research and partnerships with major life science organizations.
Something looks off?